Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Camlin Fine Sciences Limited ( (IN:CAMLINFINE) ) just unveiled an announcement.
Camlin Fine Sciences has disclosed that the Ordinary Court of Ravenna in Italy has opened judicial liquidation proceedings for its wholly owned subsidiary CFS Europe S.p.A., following an appeal by the subsidiary’s Board of Statutory Auditors in January 2026. CFS Europe contributed about 4.72% of the company’s turnover and 9.73% of its net worth in the last financial year, and court‑appointed liquidators will now manage a structured wind‑down, with any potential recovery to depend on the eventual liquidation proceeds.
The move places CFS Europe under Italy’s Code of Corporate Crisis and Insolvency, signaling a formal exit or restructuring of that unit rather than a conventional sale. While the parent company has not specified expected completion timelines or proceeds, the liquidation underlines a strategic and financial retrenchment from this European operation, and Camlin Fine Sciences has indicated it will update investors as material developments arise.
More about Camlin Fine Sciences Limited
Camlin Fine Sciences Limited operates in the specialty chemicals sector, supplying fine chemicals and performance additives with applications across food, feed, and industrial markets. Through subsidiaries such as CFS Europe S.p.A., the company has maintained a manufacturing and commercial presence in European markets, contributing a modest but notable share to its consolidated turnover and net worth.
Average Trading Volume: 36,000
Technical Sentiment Signal: Hold
Current Market Cap: 24.9B INR
For an in-depth examination of CAMLINFINE stock, go to TipRanks’ Overview page.